Therapeutic value of oncology products with a conditional approval from Health Canada: a cross-sectional study

Joel Lexchin

Open source

DOI
10.1177/20542704251325314
Published
2025-03
Container
JRSM Open
Publisher
SAGE Publications
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1177/20542704251325314,
  title = {Therapeutic value of oncology products with a conditional approval from Health Canada: a cross-sectional study},
  author = {Joel Lexchin},
  year = {2025},
  journal = {JRSM Open},
  doi = {10.1177/20542704251325314},
  url = {https://doi.org/10.1177/20542704251325314}
}

RIS

TY  - JOUR
TI  - Therapeutic value of oncology products with a conditional approval from Health Canada: a cross-sectional study
AU  - Joel Lexchin
PY  - 2025
JO  - JRSM Open
DO  - 10.1177/20542704251325314
UR  - https://doi.org/10.1177/20542704251325314
ER  - 

APA

Lexchin, J. (2025). Therapeutic value of oncology products with a conditional approval from Health Canada: a cross-sectional study. JRSM Open. https://doi.org/10.1177/20542704251325314

Source records